Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer

Aguilar-Lemarroy, Adriana; Romero-Ramos, Jose E.; Olimon-Andalon, Vicente; Hernandez-Flores, Georgina; Lerma-Diaz, Jose M.; Ortiz-Lazareno, Pablo C.; Morgan-Villela, Gilberto; Del-Toro-Arreola, Susana; Bravo-Cuellar, Alejandro; Jave-Suarez, Luis F.
January 2008
BMC Cancer;2008, Vol. 8, Special section p1
Academic Journal
Background: Currently, there is clear evidence that apoptosis plays an important role in the development and progression of tumors. One of the best characterized apoptosis triggering systems is the CD95/Fas/APO-1 pathway; previous reports have demonstrated high levels of soluble CD95 (sCD95) in serum of patients with some types of cancer. Cervical cancer is the second most common cancer among women worldwide. As a first step in an attempt to design a minimally invasive test to predict the risk of developing cervical cancer in patients with precancerous lesions, we used a simple assay based on the capacity of human serum to induce apoptosis in Jurkat cells. We evaluated the relationship between sCD95 levels and the ability to induce apoptosis in Jurkat cells in cervical cancer patients and controls. Methods: Jurkat cells were exposed to serum from 63 women (20 healthy volunteers, 21 with cervical intraepithelial neoplasia grade I [CIN 1] and 22 with cervical-uterine carcinoma). The apoptotic rate was measured by flow cytometry using Annexin-V-Fluos and Propidium Iodide as markers. Serum levels of sCD95 and soluble CD95 ligand (sCD95L) were measured by ELISA kits. Results: We found that serum from almost all healthy women induced apoptosis in Jurkat cells, while only fifty percent of the sera from women with CIN 1 induced cell death in Jurkat cells. Interestingly, only one serum sample from a patient with cervical-uterine cancer was able to induce apoptosis, the rest of the sera protected Jurkat cells from this killing. We were able to demonstrate that elimination of Jurkat cells was mediated by the CD95/Fas/Apo-1 apoptotic pathway. Furthermore, the serum levels of sCD95 measured by ELISA were significantly higher in women with cervical cancer. Conclusion: Our results demonstrate that there is a strong correlation between low levels of sCD95 in serum of normal women and higher apoptosis induction in Jurkat cells. We suggest that an analysis of the apoptotic rate induced by serum in Jurkat cells and the levels of sCD95 in serum could be helpful during the prognosis and treatment of women detected with precancerous lesions or cervical cancer.


Related Articles

  • HPV fails to boost cancer detection.  // GP: General Practitioner;6/26/2009, p23 

    The article offers information on the failure of Human Papillomavirus (HPV) tests to enhance cervical cancer detection. According to an analysis discussed in the article, physicians could not improve cancer detection through HPV tests with routine liquid-based cytology (LBC). Though HPV testing...

  • Cervical Cancer as a silent killer: A rare case report with review of literature. Pandey, Deeksha; Shetty, Jyothi; Sambhaji, Charudatt; Saxena, P. U.; Mishra, Dilip; Chawla, Arun // Journal of Cancer Research & Therapeutics;Jul-Sep2015, Vol. 11 Issue 3, Special section p653 

    Advanced-stage cervical cancer almost always presents either with abnormal vaginal bleeding or with foul-smelling vaginal discharge. We present here a rare case, where a postmenopausal lady presented almost silently with stage IVA cervical cancer. Fortunately, timely referral, correct diagnosis,...

  • Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Steenbergen, Renske D. M.; Snijders, Peter J. F.; Heideman, DaniĆ«lle A. M.; Meijer, Chris J. L. M. // Nature Reviews Cancer;Jun2014, Vol. 14 Issue 6, p395 

    Infection of cervical epithelium with high-risk human papilloma virus (hrHPV) might result in productive or transforming cervical intraepithelial neoplasia (CIN) lesions, the morphology of which can overlap. In transforming CIN lesions, aberrations in host cell genes accumulate over time, which...

  • Adenoid basal lesions of the uterine cervix: evolving terminology and clinicopathological concepts. Russell, Michael J.; Fadare, Oluwole // Diagnostic Pathology;2006, Vol. 1, p18 

    The epithelial proliferations that are designated adenoid basal carcinoma (ABC) in the current classification from the World Health Organization represent <1% of all cervical malignancies. These lesions may be associated, and occasionally show morphologic transitions with, conventional cervical...

  • Cytology of Cervical Intraepithelial Glandular Lesions.  // Collegium Antropologicum;Jun2010, Vol. 34 Issue 2, p401 

    No abstract available.

  • Cervical Cancer Screening.  // Bulletin of the World Health Organization;1993, Vol. 71 Issue 1, p122 

    The article offers information about cervical cancer. According to the author, cervical cancer is considered the most common cancer in women in developing countries. The author states that screening of cervical cancer does not affect mortality. Diagnosis and management of early cervical cancer...

  • Cervical Cancer Worry and Screening Among Appalachian Women. Kelly, Kimberly; Schoenberg, Nancy; Wilson, Tomorrow; Atkins, Elvonna; Dickinson, Stephanie; Paskett, Electra // Journal of Primary Prevention;Apr2015, Vol. 36 Issue 2, p79 

    Although many have sought to understand cervical cancer screening (CCS) behavior, little research has examined worry about cervical cancer and its relationship to CCS, particularly in the underserved, predominantly rural Appalachian region. Our mixed method investigation aimed to obtain a more...

  • ANALYSES OF CERVICALCANCER IN RAJKOT POPULATION. DHRUVA, G. A.; AGRAVAT, A. H.; BHOJANI, K. R. // Electronic Journal of Pharmacology & Therapy;2011, Vol. 4, p15 

    Cervical malignancy is the second most common cancer in women worldwide, In present study, results of 400 Pap smears are analyzed, which had been examined in cytology section (Department of Pathology, P.D.U. Medical College, Rajkot) during 2 years time duration (2009-2010).All cervical smears...

  • Can Women Self-Screen for Cervical Abnormalities? Walling, Anne D. // American Family Physician;3/1/2004, Vol. 69 Issue 5, p1235 

    Discusses research being done on the feasibility of using patient-collected samples of cervical cytology and detection of oncogenic human papillomavirus as a means of extending screening programs to women. Reference to study by F. Garcia and colleagues, published in the August 2003 issue of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics